Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial Infarction
Cardiovasc Drugs Ther
.
2024 Oct 21.
doi: 10.1007/s10557-024-07633-6.
Online ahead of print.
Authors
Daniel G Donner
1
2
3
,
Anne M Kong
4
,
Jarmon G Lees
4
5
,
Helen Kiriazis
1
3
,
Aascha Brown
1
,
Yow K Tham
1
2
3
6
,
Jessica K Holien
7
,
Hsin-Hui Shen
8
9
,
Derek J Hausenloy
10
11
12
13
,
Shiang Y Lim
14
15
16
17
Affiliations
1
Baker Heart and Diabetes Institute, Melbourne, Victoria, 3004, Australia.
2
Central Clinical School, Monash University, Melbourne, Victoria, 3004, Australia.
3
Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, 3010, Australia.
4
O'Brien Institute Department, St Vincent's Institute of Medical Research, 42 Fitzroy Street, Fitzroy, Victoria, 3065, Australia.
5
Department of Medicine and Surgery, University of Melbourne, Melbourne, VIC, Australia.
6
Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Victoria, 3086, Australia.
7
School of Science, STEM College, Engineering and Health, RMIT University, Melbourne, Victoria, Australia.
8
Department of Materials Science and Engineering, Faulty of Engineering, Monash University, Clayton, Victoria, 3800, Australia.
9
Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, 3800, Australia.
10
The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.
11
Cardiovascular and Metabolic Disorder Programme, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
12
National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore, 169609, Singapore.
13
Yong Loo Lin School of Medicine, National University Singapore, 1E Kent Ridge Road, Singapore, 119228, Singapore.
14
O'Brien Institute Department, St Vincent's Institute of Medical Research, 42 Fitzroy Street, Fitzroy, Victoria, 3065, Australia.
[email protected]
.
15
Department of Medicine and Surgery, University of Melbourne, Melbourne, VIC, Australia.
[email protected]
.
16
National Heart Research Institute Singapore, National Heart Centre, 5 Hospital Drive, Singapore, 169609, Singapore.
[email protected]
.
17
Drug Discovery Biology, Faculty of Pharmacy and Pharmaceutical Sciences, Victoria, Monash University, Parkville, VIC, Australia.
[email protected]
.
PMID:
39432235
DOI:
10.1007/s10557-024-07633-6
No abstract available
Grants and funding
104710/WT_/Wellcome Trust/United Kingdom
REF/St Vincent's Hospital Melbourne